Kitara Capital
Rediff.com » News » Kitara Capital
Web results for Kitara Capital
Jacob Ballas picks 13.1% stake in Vivimed Labs on conversion of preference shares
The conversion was at 12 per cent premium to the market price. NYLIM Jacob Ballas Fund III, managed by Jacob Ballas Capital India Pvt Ltd, has... ...
http://www.vccircle.com/news/pharmaceuticals/2013/03/22/jacob-ballas-picks-131-stake-vivimed-labs-conversion-preferencePE-backed Vivimed buys Hyderabad-based Finoso Pharma for $2.8M
This is the third acquisition in the last 18 months for Vivimed, which counts Jacob Ballas and Kitara Capital as PE investors. Public listed... ...
http://www.vccircle.com/news/pharmaceuticals/2013/02/14/pe-backed-vivimed-buys-hyderabad-based-finoso-pharma-28mRelated Tags
Top Coverage News
© 2013 Rediff.com - Investors - Advertise - Disclaimer - Privacy - Careers - Feedback | Terms of use | India Abroad weekly